Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons - Wikidata - awgldk - TriplyDB

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons

http://www.wikidata.org/entity/Q35062602

about

Sero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East Nigeria Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).Liver disease in the HIV-infected individual.Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*).Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patients.Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV.Human immunodeficiency virus infection and the liver Effects of Lifetime History of Use of Problematic Alcohol on HIV Medication Adherence.Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection Liver Enzymes Abnormalities among Highly Active Antiretroviral Therapy Experienced and HAART Naïve HIV-1 Infected Patients at Debre Tabor Hospital, North West Ethiopia: A Comparative Cross-Sectional Study.Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark.Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.Liver involvement in human immunodeficiency virus infection.Kaleidoscope of autoimmune diseases in HIV infection.Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.Changing clinical profile and factors associated with liver enzyme abnormalities among HIV-infected persons.Searching for biomarkers of comorbidities in sera of treated HIV-infected patients by isoelectric focusing.HIV Infection and TLR Signalling in the Liver.Prevalence and predictors of liver disease in HIV-infected children and adolescents.Atherosclerosis is associated with a higher risk of hepatic steatosis in HIV-infected patients.Editorial Commentary: Elevated Aminotransferase Levels Among HIV-Infected Persons: What's Lurking Under the Surface?Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.

P2860

Q28658980-244082F4-AA77-4698-A6B2-5A32A82D27FC Q30387567-2D18D3C0-0E1E-41F5-99EB-D46CC82FC2AB Q31050092-C2C7AFDA-B34C-4417-94D0-45B769DA10B0 Q33440607-4E5B1857-1723-4913-81A7-D59D25EDD8B2 Q33621724-584BE4D2-68BF-4CF4-9199-7B0B636E91F8 Q33778556-6B147EC2-A4AE-4F68-8B4B-576954475F7F Q34380326-E9B2D0B1-C0E5-49F7-AC01-FCE27B1C1F5C Q34831090-97024948-FA13-4CA8-8E1B-1D884C7BB766 Q35103486-027CDCB7-D6D0-4FBB-B396-210462033210 Q35588143-5BE7BBAC-5A70-44AB-8C69-56D3829A34F2 Q35628262-2A4AC599-1CC7-48FE-B244-0EC08AFA5B2A Q35846104-B943300E-9E6A-46D8-AAD3-ED29041ED3E0 Q35875848-B1AECC89-1198-4478-A451-C6E041E9A54B Q36519344-309ED624-D17F-48F5-8C1E-985F13DD3610 Q37056681-2483FC49-4FAA-49A4-BC5F-6D09D2C06D34 Q37132172-31B460A1-2701-4E96-81DC-884C984618C8 Q37357476-ED255A21-790A-46B5-9540-A3E9DF73BC16 Q37442717-3FC63B1F-3C1A-4A4F-BA0D-E9B1D2412D76 Q38612748-D1268C4A-27D7-474C-8C4E-5DF047B0FC4E Q38852184-89593FE8-A7D2-4557-BF50-C5CA1AA75699 Q38932786-EE7DCBE9-B367-45C9-8BD3-622C07B9828A Q40271245-31614C3E-B458-48A2-A8D9-B0CDA0C2E3EE Q40637208-1476E64D-12E2-44E2-91D8-C1A8F07E2728 Q41516789-7C45920E-8166-4B0A-B3F5-F14416867E1E Q41814282-9DE60070-5BB2-4849-9BEE-175123F92F36 Q41929658-3FA57F51-FE7C-4BFF-A9DB-DF41CF4935DA Q43163566-C785EFC4-24EA-476F-AB16-7B6A3944BC0A Q46094964-80AC32B5-22D1-4D23-A2B7-B0A7B816C648 Q55310223-267C2C9D-97F8-4D70-A1F3-DBAF94AD7158

P2860

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons

http://www.wikidata.org/entity/Q35062602

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prevalence and factors associa ...... iciency virus-infected persons

@ast

Prevalence and factors associa ...... iciency virus-infected persons

@en

type

label

Prevalence and factors associa ...... iciency virus-infected persons

@ast

Prevalence and factors associa ...... iciency virus-infected persons

@en

prefLabel

Prevalence and factors associa ...... iciency virus-infected persons

@ast

Prevalence and factors associa ...... iciency virus-infected persons

@en

P1433

Q35062602-6DAF2D9C-CB8E-4360-8C14-4687B52992AF

P1476

Q35062602-24182126-2334-4684-954F-07C8FD140329

P2093

Q35062602-40368E88-27F9-47BC-A185-4DC9067E06FD

Q35062602-5ABFD4AC-BCF0-40FB-8E19-71EC1EAC9410

Q35062602-6B03AB24-4994-4A5F-8657-AD1E406061D6

Q35062602-6B586750-9A17-48A4-AF12-1F23532EF93F

Q35062602-81D941A2-487C-496A-B2B3-C1184F033A0F

Q35062602-827EAF33-FD16-4CE7-AFBB-73EACABFF6AB

Q35062602-A3F29598-5F3C-42BC-BCDB-3496EC454E6A

Q35062602-B37B6EFC-3F8B-4634-9364-DEE40D1F8C33

P2860

Q35062602-0BC9B0FB-A019-4E52-9148-FA2787B165E0

Q35062602-1E83EBF2-19DE-40AF-AD23-8D00A26FB472

Q35062602-215ADF8B-A83B-4842-B5DF-D75641507D7B

Q35062602-32CF2B4F-97FD-4930-BB58-AF38355351D1

Q35062602-33197C62-7123-4955-91B2-8FDD05186215

Q35062602-36ACCA1C-15CF-4307-AED2-57CB86BFAB74

Q35062602-461CF6C7-7609-4797-A78B-5EC3DDC433D5

Q35062602-51E4D57B-BCB9-4626-B4F2-51B91F8647DC

Q35062602-5306A947-AC05-4FD4-AA8D-A68FE5A17932

Q35062602-5C887E36-1B43-4D7E-9C46-F58BB46F66C0

P304

Q35062602-37F82BFF-9594-4746-8298-FD21962343F8

P31

Q35062602-AAEE1F74-ED30-4CE8-9DD2-9C4C30938A8B

P356

Q35062602-DEA6F2C1-3703-4FFF-81A0-4620EFCA8ACB

P407

Q35062602-3131C397-E770-4FA3-B2EB-2FAE50717BE6

P433

Q35062602-555AFD5B-C91A-4FC8-B1D5-40E048C1F5A8

P478

Q35062602-6988836D-F8AD-4FE0-84B2-F3A25FF59098

P577

Q35062602-53050BA7-754C-46CF-8DC6-A3385BA31D68

P5875

Q35062602-8F878A4D-D635-4834-8454-7334E9A6C574

P698

Q35062602-DC2B9309-8792-431D-A662-0C11977C6000

P932

Q35062602-98E9BD40-C46D-4231-86FA-F22D474D9E72

P356

J.CGH.2009.09.025

P1433

Clinical Gastroenterology and Hepatology

P1476

Prevalence and factors associa ...... iciency virus-infected persons

@en

P2093

Braden Hale

http://www.w3.org/2001/XMLSchema#string

Charles Hames

http://www.w3.org/2001/XMLSchema#string

Dean Asher

http://www.w3.org/2001/XMLSchema#string

Gary Collins

http://www.w3.org/2001/XMLSchema#string

Mary Bavaro

http://www.w3.org/2001/XMLSchema#string

Nancy Crum-Cianflone

http://www.w3.org/2001/XMLSchema#string

Richard Campin

http://www.w3.org/2001/XMLSchema#string

Sheila Medina

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Evaluation of abnormal liver-enzyme results in asymptomatic patients.

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

Antiretroviral drug toxicity -- a challenge for the hepatologist?

Hepatobiliary complications in patients with human immunodeficiency virus infection.

Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase.

The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections

P304

183-191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2009.09.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26867264

http://www.w3.org/2001/XMLSchema#string

P698

19800985

http://www.w3.org/2001/XMLSchema#string

P932

3121187

http://www.w3.org/2001/XMLSchema#string